Overview
David Mann is a Hematologist Oncology specialist and a Hematologist in Andalusia, Alabama. Dr. Mann and is rated as an Experienced provider by MediFind in the treatment of Porphyria. His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Lung Cancer, and Pleuropulmonary Blastoma. Dr. Mann is currently accepting new patients.
Insurance
Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.
Accepted insurance plans
- Cigna
- AvMed
- Blue Cross Blue Shield
- Health Options
- Humana
- Florida Blue
Locations
104 Medical Park Dr, Andalusia, AL 36420
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
MediFind cannot find any recent clinical research or clinical trials for Dr. David E. Mann
Areas of Expertise
When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
To learn more about how MediFind determines the expertise levels, check out our expert tiers page.
- Distinguished
- Angiosarcoma
- B-Cell Lymphoma
- Colorectal Cancer
- Familial Colorectal Cancer
- Inflammatory Breast Cancer
- Lung Cancer
- Advanced
- Adult Immune Thrombocytopenia
- ALK-Positive Non-Small Cell Lung Cancer
- Alpha Thalassemia
- Alpha Thalassemia X-Linked Intellectual Disability Syndrome
- Anemia
- Breast Cancer
- Experienced
- Acute Hepatic Porphyria (AHP)
- Acute Lymphoblastic Leukemia (ALL)
- Acute Mountain Sickness
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)